PL90026B1 - - Google Patents
Download PDFInfo
- Publication number
- PL90026B1 PL90026B1 PL1970173771A PL17377170A PL90026B1 PL 90026 B1 PL90026 B1 PL 90026B1 PL 1970173771 A PL1970173771 A PL 1970173771A PL 17377170 A PL17377170 A PL 17377170A PL 90026 B1 PL90026 B1 PL 90026B1
- Authority
- PL
- Poland
- Prior art keywords
- formula
- carbon atoms
- alkyl
- alkoxy
- halogen
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/275—Nitriles; Isonitriles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C255/00—Carboxylic acid nitriles
- C07C255/49—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
- C07C255/53—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing cyano groups and hydroxy groups bound to the carbon skeleton
-
- E—FIXED CONSTRUCTIONS
- E04—BUILDING
- E04H—BUILDINGS OR LIKE STRUCTURES FOR PARTICULAR PURPOSES; SWIMMING OR SPLASH BATHS OR POOLS; MASTS; FENCING; TENTS OR CANOPIES, IN GENERAL
- E04H13/00—Monuments; Tombs; Burial vaults; Columbaria
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Architecture (AREA)
- Civil Engineering (AREA)
- Structural Engineering (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
Description
Przedmiotem wynalazku jest sposób wytwarzania nowych racemicznych lub optycznie czynnych 1-feno- ksy-2-hydroksy-3^cykloalkiloaminopropanów i ich soli addycyjnych z kwasami.Nowym zwiazkom odpowiada wzór 1, w którym R oznacza grupe alkilowa, zawierajaca do 5 atomów wegla, Ri oznacza wodór, chlorowiec, grupe nitrylowa lub alkilowa, alkoksylowa lub alkenylowa, zawierajaca do atomów wegla, R2 oznacza wodór, chlorowiec, grupe alkilowa lub alkoksylowa, zawierajaca do 5 atomów wegla i n oznacza liczbe calkowita 2—7.Wedlug wynalazku nowe zwiazki o wzorze 1 wytwarza sie przez redukcje zwiazku o wzorze 2, w którym wszystkie symbole maja wyzej podane znaczenie.Zwiazki o wzorze 2 zawieraja juz gotowy szkielet 1-fenoksy-2-hydroksy-3-cykloalkiloaminopropanu i mozna je wytwarzac przez reakcje odpowiedniego fenolu z epichlorohydryna i nastepnie reakcje otrzymanego 1-fenoksy-2,3-epoksypropanu z cykloalkiloamina.Zwiazki otrzymywane sposobem wedlug wynalazku posiadaja asymetryczny atom wegla w grupie CHOH i moga wystepowac przeto w postaci racematów lub jako optycznie czynne antypody. Te ostatnie mozna otrzymywac przez rozdzielenie racematu za pomoca zwykle uzywanych kwasów pomocniczych, takich jak kwas dwubenzoilo-D-winowy lub D-3-bromokamforo-8-sulfonowy, a równiez przez stosowanie optycznie czynnych zwiazków wyjsciowych.Otrzymywane sposobem wedlug wynalazku zwiazki, to jest 1-fenoksy-3-cykloalkiloaminopropanole o wzo¬ rze 1 mozna w znany sposób przeprowadzic w ich fizjologicznie dopuszczalne sole addycyjne z kwasami.Odpowiednimi kwasami sa, np. kwas solny, kwas bromowodorowy, kwas siarkowy, kwas metanosulfonowy, kwas maleinowy, kwas octowy, kwas szczawiowy, kwas mlekowy, kwas winowy lub 8-chloroteofilina.Zwiazki o wzorze 1 wzglednie ich fizjologicznie dopuszczalne sole addycyjne z kwasami wykazuja w badaniach na swinkach mprskich jako zwierzetach doswiadczalnych, wartosciowe wlasciwosci terapeutyczne, w szczególnosci dzialanie 0-adrenolityczne, mozna je wiec stosowac, np. do leczenia lub profilaktyki schorzen wiencowych serca i arytmii serca, w szczególnosci tachycardii, w medycynie. Równiez dzialanie obnizajace cisnienie krwi tych zwiazków jest pod wzgledem terapeutycznym interesujace.Dawka jednostkowa zwiazków otrzymywanych sposobem wedlug wynalazku wynosi 1—300 mg, zwlaszcza —100 mg (doustnie) wzglednie 1-20 mg (pozajelitowo).2 90 026 Galonowa obróbke zwiazków otrzymywanych sposobem wedlug wynalazku do zwykle stosowanych form uzytkowych, takich jak roztwory, emulsje, tabletki, drazetki lub preparaty o przedluzonym dzialaniu, prowadzi sie w znany sposób, z zastosowaniem zwyklych galenowych srodków pomocniczych, nosników, srodków rozkruszajacych, wiazacych, powlokowych, poslizgowych, substancji smakowych, slodzacych, srodków powodu¬ jacych efekt przedluzonego dzialania lub ulatwiajacych rozpuszczanie. Zwiazki otrzymywane sposobem wedlug wynalazku mozna równiez laczyc z innymi farmakodynamicznie czynnymi substancjami, takimi jak, np. substan¬ cje rozszerzajace naczynia wiencowe, sympatykomimetyczne, glikozydy nasercowe lub srodki uspokajajace.Przyklad. Dwuchlorowodorek 1-(2-aminofenoksy)-2-hydroksy-3-(1-metylocykloheksyloamino)-propa- nu, ,4 g (0,05 mola) zasady 1-(2-nitrofenoksy)-2-hydroksy-3-(1-metylocykloheksyloamino)"propanu rozpusz¬ cza sie w metanolu i uwodornia wobec niklu Raney'a pod normalnym cisnieniem. Po odciagnieciu katalizatora i oddestylowaniu rozpuszczalnika, pozostalosc przeprowadza sie za pomoca eterowego roztworu HCI w dwuchlo¬ rowodorek, który przekrystalizowuje sie dwukrotnie z metanolu dodajac eteru. Wydajnosc: 3,6 g, temperatura topnienia dwuchlorowodorku: 235—237°C. PL PL PL PL PL PL
Claims (3)
1. Z a s t r z e z e n i e p a t e n t o we Sposób wytwarzania nowych 1. -fenoksy-
2. -hydroksy-
3. -cykloalkiloaminopropanów o wzorze 1, w którym R oznacza grupe alkilowa, zawierajaca do 5 atomów wegla, Ri oznacza wodór, chlorowiec, grupe nitrylowa lub grupe alkilowa, alkoksylowa lub alkenylowa, zawierajaca do 5 atomów wegla, R2 oznacza wodór, chlorowiec, grupe alkilowa lub alkoksylowa, zawierajaca do 5 atomów wegla i n oznacza liczbe calkowita 2—7 w postaci racematu lub izomerów optycznie czynnych oraz ich fizjologicznie dopuszczalnych soli addycyjnych z kwasami, znamienny tym, ze zwiazek o wzorze 2, w którym wszystkie symbole maja wyzej podane znaczenie, poddaje sie redukcji i otrzymany zwiazek o wzorze 1, o ile wystepuje w postaci racematu ewentualnie przeprowa¬ dza sie za pomoca odpowiednich kwasów pomocniczych wdiastereomeryczne sole, które rozdziela sie na drodze frakcjonowanej krystalizacji i zwiazki o wzorze 1 ewentualnie przeprowadza w ich fizjologicznie dopuszczalne sole addycyjne z kwasami. V0CH2-CH0H-CH2-NH-(^H2)n R WZÓR 1 0CH-CH0H-CH2-NH-CtH2)n 2 I R WZtiR 2 Prac. Poligraf. UP PRL. Naklad 120+18 Cena 10 zl PL PL PL PL PL PL
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE1937477A DE1937477C3 (de) | 1969-07-23 | 1969-07-23 | I -Phenoxy-2-hydroxy-3-(l -methylcycloalkylamino)-propane, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel |
Publications (1)
Publication Number | Publication Date |
---|---|
PL90026B1 true PL90026B1 (pl) | 1976-12-31 |
Family
ID=5740681
Family Applications (9)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL1970173770A PL90027B1 (pl) | 1969-07-23 | 1970-07-21 | |
PL1970142196A PL79772B1 (pl) | 1969-07-23 | 1970-07-21 | |
PL1970173765A PL90039B1 (pl) | 1969-07-23 | 1970-07-21 | |
PL1970173766A PL90038B1 (pl) | 1969-07-23 | 1970-07-21 | |
PL1970173769A PL90028B1 (pl) | 1969-07-23 | 1970-07-21 | |
PL1970173767A PL90030B1 (pl) | 1969-07-23 | 1970-07-21 | |
PL1970173771A PL90026B1 (pl) | 1969-07-23 | 1970-07-21 | |
PL1970173768A PL90029B1 (pl) | 1969-07-23 | 1970-07-21 | |
PL1970173772A PL90025B1 (pl) | 1969-07-23 | 1970-07-21 |
Family Applications Before (6)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL1970173770A PL90027B1 (pl) | 1969-07-23 | 1970-07-21 | |
PL1970142196A PL79772B1 (pl) | 1969-07-23 | 1970-07-21 | |
PL1970173765A PL90039B1 (pl) | 1969-07-23 | 1970-07-21 | |
PL1970173766A PL90038B1 (pl) | 1969-07-23 | 1970-07-21 | |
PL1970173769A PL90028B1 (pl) | 1969-07-23 | 1970-07-21 | |
PL1970173767A PL90030B1 (pl) | 1969-07-23 | 1970-07-21 |
Family Applications After (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL1970173768A PL90029B1 (pl) | 1969-07-23 | 1970-07-21 | |
PL1970173772A PL90025B1 (pl) | 1969-07-23 | 1970-07-21 |
Country Status (17)
Country | Link |
---|---|
US (1) | US3755413A (pl) |
JP (5) | JPS5133106B1 (pl) |
AT (9) | AT304476B (pl) |
BE (1) | BE753774A (pl) |
BG (9) | BG17508A3 (pl) |
CH (10) | CH536812A (pl) |
CS (9) | CS170528B2 (pl) |
DE (1) | DE1937477C3 (pl) |
DK (1) | DK140281B (pl) |
ES (8) | ES382014A1 (pl) |
FR (1) | FR2059551B1 (pl) |
GB (1) | GB1314896A (pl) |
NL (1) | NL169874C (pl) |
PL (9) | PL90027B1 (pl) |
RO (9) | RO59209A (pl) |
SE (1) | SE370391B (pl) |
YU (5) | YU34395B (pl) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4021576A (en) * | 1969-07-23 | 1977-05-03 | Boehringer Ingelheim Gmbh | Pharmaceutical compositions containing a 1-(2'-ethynyl-phenoxy)-2-hydroxy-3-(cycloalkyl-amino)-propane and method of use |
US3937706A (en) * | 1969-07-23 | 1976-02-10 | Boehringer Ingelheim Gmbh | 1-(2'ethynyl-phenoxy)-2-hydroxy-3-(cycloalkyl-amino)-propanes and salts thereof |
US4120978A (en) * | 1970-01-08 | 1978-10-17 | Ciba-Geigy Corporation | Pharmaceutical composition for inhibiting and blocking cardioselective beta-receptors |
US4038313A (en) * | 1970-01-08 | 1977-07-26 | Ciba-Geigy Corporation | Cycloalkylureido phenoxy propanolamines |
SE354851B (pl) * | 1970-02-18 | 1973-03-26 | Haessle Ab | |
US4145442A (en) * | 1972-04-04 | 1979-03-20 | Aktiebolaget Hassle | Phenoxy-hydroxypropylamines, their preparation, and method and pharmaceutical preparations for treating cardiovascular diseases |
US4038414A (en) * | 1972-06-08 | 1977-07-26 | Ciba-Geigy Corporation | Amines and processes for their manufacture |
US4035420A (en) * | 1972-07-06 | 1977-07-12 | Aktiebolaget Hassle | Substituted ureido alkylene phenoxy propanolamines |
DE2309887C2 (de) * | 1973-02-28 | 1983-11-10 | C.H. Boehringer Sohn, 6507 Ingelheim | 1-Aryloxy-2-hydroxy-3-alkinylaminopropan-Derivate und deren physiologisch verträgliche Säureadditionssalze, pharmazeutische Präparate und Herstellungsverfahren für die Verbindungen |
US4220659A (en) * | 1974-02-22 | 1980-09-02 | Boehringer Ingelheim Gmbh | 1-Phenoxy-2-hydroxy-3-alkynylamino-propanes and salts thereof |
DE2540552A1 (de) * | 1974-09-12 | 1976-03-25 | American Cyanamid Co | Cycloalkylderivate von 1-aryloxy-3- amino-2-propanolen |
US4165384A (en) * | 1974-11-01 | 1979-08-21 | Aktiebolaget Hassle | Amide substituted phenoxy propanol amines |
US4387103A (en) * | 1980-11-28 | 1983-06-07 | American Hospital Supply Corporation | Method for treatment or prophylaxis of cardiac disorders |
US4471127A (en) * | 1981-09-08 | 1984-09-11 | Ciba-Geigy Corporation | 1-5-Bis-(1,4-benzodioxin-2-yl)-3-azapentane-1,5-diols |
US5039801A (en) * | 1985-12-20 | 1991-08-13 | The United States Of America As Represented By The Department Of Health & Human Services | Thermal fragmentation of methylbenzylurea disastereomers or secondary amines and preparation of optically active secondary amines |
JPS6364630U (pl) * | 1986-10-17 | 1988-04-28 |
-
1969
- 1969-07-23 DE DE1937477A patent/DE1937477C3/de not_active Expired
-
1970
- 1970-03-22 BG BG017138A patent/BG17508A3/xx unknown
- 1970-03-23 BG BG017134A patent/BG17750A3/xx unknown
- 1970-07-16 CH CH224773A patent/CH536812A/de not_active IP Right Cessation
- 1970-07-16 CH CH224873A patent/CH536813A/de not_active IP Right Cessation
- 1970-07-16 CH CH224973A patent/CH550139A/xx not_active IP Right Cessation
- 1970-07-16 CH CH224373A patent/CH570363A5/xx not_active IP Right Cessation
- 1970-07-16 CH CH1106675A patent/CH575376A5/xx not_active IP Right Cessation
- 1970-07-16 CH CH224273A patent/CH536809A/de not_active IP Right Cessation
- 1970-07-16 CH CH224573A patent/CH536810A/de not_active IP Right Cessation
- 1970-07-16 CH CH224673A patent/CH536811A/de not_active IP Right Cessation
- 1970-07-16 CH CH1087370A patent/CH537360A/de not_active IP Right Cessation
- 1970-07-16 CH CH224473A patent/CH550140A/xx not_active IP Right Cessation
- 1970-07-20 RO RO69804A patent/RO59209A/ro unknown
- 1970-07-20 RO RO69801A patent/RO59112A/ro unknown
- 1970-07-20 RO RO69799A patent/RO60112A/ro unknown
- 1970-07-20 RO RO69803A patent/RO59159A/ro unknown
- 1970-07-20 RO RO63988A patent/RO56318A/ro unknown
- 1970-07-20 RO RO69802A patent/RO59089A/ro unknown
- 1970-07-20 RO RO69798A patent/RO60111A/ro unknown
- 1970-07-20 RO RO69805A patent/RO59210A/ro unknown
- 1970-07-20 RO RO69806A patent/RO59211A/ro unknown
- 1970-07-21 PL PL1970173770A patent/PL90027B1/pl unknown
- 1970-07-21 GB GB3535970A patent/GB1314896A/en not_active Expired
- 1970-07-21 PL PL1970142196A patent/PL79772B1/pl unknown
- 1970-07-21 CS CS4505A patent/CS170528B2/cs unknown
- 1970-07-21 PL PL1970173765A patent/PL90039B1/pl unknown
- 1970-07-21 ES ES382014A patent/ES382014A1/es not_active Expired
- 1970-07-21 PL PL1970173766A patent/PL90038B1/pl unknown
- 1970-07-21 CS CS4502A patent/CS170525B2/cs unknown
- 1970-07-21 CS CS4504A patent/CS170527B2/cs unknown
- 1970-07-21 PL PL1970173769A patent/PL90028B1/pl unknown
- 1970-07-21 CS CS4503A patent/CS170526B2/cs unknown
- 1970-07-21 PL PL1970173767A patent/PL90030B1/pl unknown
- 1970-07-21 PL PL1970173771A patent/PL90026B1/pl unknown
- 1970-07-21 CS CS4506A patent/CS170529B2/cs unknown
- 1970-07-21 PL PL1970173768A patent/PL90029B1/pl unknown
- 1970-07-21 CS CS5136A patent/CS170524B2/cs unknown
- 1970-07-21 CS CS4509A patent/CS170532B2/cs unknown
- 1970-07-21 PL PL1970173772A patent/PL90025B1/pl unknown
- 1970-07-21 CS CS4507A patent/CS170530B2/cs unknown
- 1970-07-21 CS CS4508A patent/CS170531B2/cs unknown
- 1970-07-22 BG BG017137A patent/BG18852A3/xx not_active Expired
- 1970-07-22 BG BG018645A patent/BG19132A3/xx unknown
- 1970-07-22 BG BG015254A patent/BG17749A3/xx unknown
- 1970-07-22 YU YU1860/70A patent/YU34395B/xx unknown
- 1970-07-22 BG BG017135A patent/BG17751A3/xx unknown
- 1970-07-22 DK DK380170AA patent/DK140281B/da unknown
- 1970-07-22 BG BG017136A patent/BG17507A3/xx unknown
- 1970-07-22 JP JP45063634A patent/JPS5133106B1/ja active Pending
- 1970-07-22 BE BE753774D patent/BE753774A/xx not_active IP Right Cessation
- 1970-07-22 US US00057353A patent/US3755413A/en not_active Expired - Lifetime
- 1970-07-23 AT AT118372A patent/AT304476B/de not_active IP Right Cessation
- 1970-07-23 AT AT118672A patent/AT306704B/de not_active IP Right Cessation
- 1970-07-23 AT AT118272A patent/AT304475B/de active
- 1970-07-23 NL NLAANVRAGE7010928,A patent/NL169874C/xx not_active IP Right Cessation
- 1970-07-23 AT AT674870A patent/AT303706B/de not_active IP Right Cessation
- 1970-07-23 SE SE7010200A patent/SE370391B/xx unknown
- 1970-07-23 AT AT117972A patent/AT306702B/de not_active IP Right Cessation
- 1970-07-23 FR FR7027291A patent/FR2059551B1/fr not_active Expired
- 1970-07-23 AT AT118472A patent/AT304477B/de not_active IP Right Cessation
- 1970-07-23 AT AT118072A patent/AT306703B/de not_active IP Right Cessation
- 1970-07-23 AT AT118572A patent/AT304478B/de active
- 1970-07-23 AT AT118172A patent/AT304474B/de active
- 1970-07-24 BG BG017133A patent/BG17506A3/xx unknown
- 1970-07-24 BG BG017132A patent/BG17505A3/xx unknown
-
1971
- 1971-09-09 ES ES394915A patent/ES394915A1/es not_active Expired
- 1971-09-09 ES ES394917A patent/ES394917A1/es not_active Expired
- 1971-09-09 ES ES394918A patent/ES394918A1/es not_active Expired
- 1971-09-09 ES ES394916A patent/ES394916A1/es not_active Expired
- 1971-09-09 ES ES394913A patent/ES394913A1/es not_active Expired
- 1971-09-09 ES ES394914A patent/ES394914A1/es not_active Expired
- 1971-09-09 ES ES394919A patent/ES394919A1/es not_active Expired
-
1973
- 1973-06-06 JP JP48063728A patent/JPS5210861B1/ja active Pending
- 1973-06-06 JP JP48063730A patent/JPS5210863B1/ja active Pending
- 1973-06-06 JP JP48063729A patent/JPS5210862B1/ja active Pending
- 1973-06-06 JP JP48063727A patent/JPS5238556B1/ja active Pending
-
1975
- 1975-10-07 YU YU2545/75A patent/YU34662B/xx unknown
- 1975-10-07 YU YU2546/75A patent/YU34663B/xx unknown
- 1975-10-07 YU YU2544/75A patent/YU34396B/xx unknown
- 1975-10-07 YU YU2551/75A patent/YU34113B/xx unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PL90026B1 (pl) | ||
PL166582B1 (pl) | Sposób wytwarzania nowych pochodnych amin aromatycznych PL PL | |
DE2645710A1 (de) | Phenoxy-amino-propanole und verfahren zu ihrer herstellung | |
DD263980A5 (de) | Verfahren zur herstellung von neuen diphenyl-propylamin-derivaten | |
JPS6221343B2 (pl) | ||
JPS649994B2 (pl) | ||
JP3058746B2 (ja) | 置換n−フェニルピペリジン | |
US4460605A (en) | 2-[2'-Hydroxy-3'-(1,1-dimethylpropylamino)-propoxy]-β-phenylpropiophenone, its physiologically acceptable acid addition salts, and pharmaceutical compositions | |
US4067904A (en) | Alkylsulfonylphenoxypropanolamine derivatives | |
DD201305A5 (de) | Verfahren zur herstellung von in 7-stellung substituierten benzopyranen | |
JP2569088B2 (ja) | 塩基性置換フェニルアセトニトリル及びカルシウム拮抗作用を有する心血管系疾患の治療剤 | |
DE2020864B2 (de) | p-Substituierte 1-Phenoxy-3-alkylaminopropan-2-ole, Herstellungsverfahren und Arzneimittel | |
EP0576766A1 (en) | Propanolamine derivatives, their preparation and use | |
JPS6326099B2 (pl) | ||
US5149714A (en) | Antidepressants | |
US4490392A (en) | Benzylalcohol derivative and process for preparing | |
PL84396B1 (pl) | ||
SK6412000A3 (en) | Biphenyl derivatives as pharmaceuticals | |
US5055490A (en) | Stereoisomers of benzonitrile derivatives, useful as cardiac arrhythmiac agents | |
JPS60136557A (ja) | 置換2―ヒドロキシ―プロピオフェノンのアミノプロパノール誘導体、その製法及び抗不整脈剤 | |
KR840002104B1 (ko) | 신규 이소퀴놀린 유도체의 제법 | |
DK144159B (da) | Analogifremgangsmaade til fremstilling af 3-(trifluormethylphenyl)-2-aminoprppanderivater eller syreadditionssalte heraf | |
JPH0819061B2 (ja) | アミノアルコ−ル類 | |
DK144299B (da) | Analogifremgangsmaade til fremstilling af 1-fenyl2-amino-1,3-propandiol-n-alkyl-derivater eller fysiologisk acceptable salte deraf | |
DE2950064A1 (de) | Piperidinderivate von 3-hydroxythiophen-2-carbonsaeure und -estern, ihre herstellung und diese enthaltende pharmazeutische zubereitungen |